• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Epiris to acquire Diamorph

  • Kenny Wastell
  • Kenny Wastell
  • @kennywastell
  • 21 November 2018
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Epiris has agreed to wholly acquire Swedish precision materials company Diamorph from Serendipity Ixora and industrial holdings firm Latour.

Financial details of the transaction remain undisclosed, though Unquote sister publication Mergermarket reports that the deal values the business at SEK 1.4-1.5bn.

Latour will sell its 28.2% stake in the company for SEK 290m, following a six-year holding period.

Diamorph

  • DEAL:

    SBO

  • VALUE:

    n/d (SEK 1.4-1.5bn est)

  • LOCATION:

    Stockholm

  • SECTOR:

    Speciality chemicals

  • FOUNDED:

    2003

  • STAFF:

    270

  • VENDOR:

    Serendipity Ixora

Epiris is currently investing from £821m fund Epiris II, which held a final close in October and is the firm's first vehicle as an independent fund manager. The fund primarily invests in UK companies and writes equity cheques of £40-150m for businesses with enterprise values of up to £500m.

Prior to the latest deal, Epiris II had made four acquisitions: auction house Bonhams, country club operator The Club Company, the UK publishing division of Time Inc and substrate manufacturer Portals De La Rue.

The transaction is scheduled for completion by the end of January 2019.

Previous funding
Latour first invested in Diamorph in 2012, and provided SEK 164m of equity funding throughout its holding period.

Company
Founded in 2003 in a spin-out from Stockholm University, Diamorph is a manufacturer of industrial materials designed for high temperatures, chemical stability and fire protection. Its products are used in the building of ships and freight trains, renewable energy generation and in manufacturing machinery for the production of ceramic tiles, glass and aluminium plate.

The group also comprises UK-based Tenmat and Czech Republic-headquartered Diamorph Hob Certec; it has sales offices in four additional countries. Diamorph exports its products to 60 countries and has a total headcount of around 270 employees.

People
Epiris – Alex Fortescue (managing partner); Charles Elkington (partner); Pamela Brent (investment manager); Aaron Atwal (investment associate).
Latour – Anders Mörck (chief financial officer).
Diamorph – Gordon MacLeman (CEO).

Advisers
Equity – Roland Berger & Partners (commercial due diligence); PwC (corporate finance); Ropes & Gray (legal).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Nordics
  • Industrials
  • Sweden
  • Epiris
  • PwC
  • Ropes & Gray
  • Roland Berger & Partners

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013